Big leaps in science are presenting parents with choices that were once impossible — screening the DNA of embryos to help pick a future child with lower risks of disease, and higher odds of being taller or even smarter. But with the new technology comes a renewed ethical debate. Tony Dokoupil spoke to Nucleus Genomics CEO Kian Sadeghi.
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
